Product Program year 2024 Source: CMS Open Payments

Imdelltra (Amg 757)

Biological Hematology

Open in the dashboard

General payments

$41,952

149 payments

Research payments

$0

0 payments

Through program year 2024, $41,952 in general payments and $0 in research payments were reported against Imdelltra (Amg 757) (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $41,952 149

Breakdown

Who paid General payments · program year 2024
  1. Amgen Inc. $41,952 149 payments
Top recipients General payments · program year 2024
  1. Robert Kaner Pulmonary Disease · New York, NY $10,976 26% · 1 payment
  2. Jeffrey Clarke Durham, NC $8,840 21% · 1 payment
  3. Philip Lammers Hematology & Oncology · Bartlett, TN $3,211 8% · 2 payments
  4. Frederick Schnell Macon, GA $3,000 7% · 2 payments
  5. Rafael Santana Davila Hematology & Oncology · Seattle, WA $2,717 6% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pulmonary Disease Internal Medicine $10,976 36% · 1 practitioner
  2. Hematology & Oncology Internal Medicine $10,105 34% · 31 practitioners
  3. Medical Oncology Internal Medicine $2,465 8% · 24 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $2,430 8% · 27 practitioners
  5. Nurse Practitioner $1,697 6% · 17 practitioners

The top 5 of 15 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $11,227 27% · 3 recipients
  2. North Carolina $9,364 22% · 3 recipients
  3. Tennessee $3,897 9% · 7 recipients
  4. Georgia $3,079 7% · 3 recipients
  5. Washington $2,717 6% · 1 recipient

The top 5 of 27 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

149 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record